- Home
- ASPS vs MIST Comparison
ASPS vs MIST Comparison
Compare ASPS & MIST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ASPS
- MIST
- Stock Information
- Founded
- ASPS 1999
- MIST 2003
- Country
- ASPS Luxembourg
- MIST Canada
- Employees
- ASPS N/A
- MIST N/A
- Industry
- ASPS Other Consumer Services
- MIST Biotechnology: Pharmaceutical Preparations
- Sector
- ASPS Consumer Discretionary
- MIST Health Care
- Exchange
- ASPS Nasdaq
- MIST Nasdaq
- Market Cap
- ASPS 150.8M
- MIST 132.5M
- IPO Year
- ASPS N/A
- MIST N/A
- Fundamental
- Price
- ASPS $11.50
- MIST $1.58
- Analyst Decision
- ASPS
- MIST Strong Buy
- Analyst Count
- ASPS 0
- MIST 2
- Target Price
- ASPS N/A
- MIST $7.50
- AVG Volume (30 Days)
- ASPS 40.2K
- MIST 2.8M
- Earning Date
- ASPS 07-24-2025
- MIST 08-07-2025
- Dividend Yield
- ASPS N/A
- MIST N/A
- EPS Growth
- ASPS N/A
- MIST N/A
- EPS
- ASPS N/A
- MIST N/A
- Revenue
- ASPS $168,271,000.00
- MIST N/A
- Revenue This Year
- ASPS $38.29
- MIST N/A
- Revenue Next Year
- ASPS N/A
- MIST N/A
- P/E Ratio
- ASPS N/A
- MIST N/A
- Revenue Growth
- ASPS 12.96
- MIST N/A
- 52 Week Low
- ASPS $3.46
- MIST $0.63
- 52 Week High
- ASPS $15.96
- MIST $2.75
- Technical
- Relative Strength Index (RSI)
- ASPS 50.42
- MIST 45.40
- Support Level
- ASPS $12.22
- MIST $1.48
- Resistance Level
- ASPS $14.21
- MIST $1.64
- Average True Range (ATR)
- ASPS 1.69
- MIST 0.17
- MACD
- ASPS -0.29
- MIST -0.04
- Stochastic Oscillator
- ASPS 27.00
- MIST 18.33
About ASPS Altisource Portfolio Solutions S.A.
Altisource Portfolio Solutions SA is an integrated service provider and marketplace for the real estate and mortgage industries. It operates via two reportable segments, namely Servicer and Real Estate, which derive maximum revenue, and Origination. The Servicer and Real Estate segment provides loan servicers and real estate investors with solutions and technologies that span the mortgage and real estate lifecycle. The Origination segment provides originators with solutions and technologies that span the mortgage origination lifecycle. Altisource mainly serves financial institutions, government-sponsored enterprises, and originators in the United States, with the majority of its revenue flowing from field services and mortgage and real estate solutions.
About MIST Milestone Pharmaceuticals Inc.
Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular medicines. Etripamil is a calcium channel blocker developed as a rapid-onset nasal spray to be administered by the patient to treat episodes of paroxysmal supraventricular tachycardia, or PSVT. The company has an ongoing Phase 2 clinical trial for patients with atrial fibrillation experiencing a rapid ventricular rate (AFib-RVR).